[Gynazol for treatment of vulvo-vaginal candidiasis--our experience].
OBJECTIVE
to have a personal experience concerning the therapeutic characteristics of the new product GYNAZOL (Gedeon Richter, Ltd)--5 g. vaginal cream for treatment of vulvo-vaginal candidosis (VVC).


METHODS
31 women in reproductive and climacteric age suffering from acute or chronic VVC.


METHODS
inquiry, clinical and laboratory.


RESULTS
25 patients were clinically cured of VVC, 5 reported an improvement, 1-changed for the worse; in 27 microscopic investigation is negative for yeasts; in 20 the improvement is established in 1-3 days; the patient's evaluation is very good and good in 26 of them; 25 patients reported high acceptance.


CONCLUSIONS
Vaginal cream GYNAZOL (Gedeon Richter, Ltd) is high effective for the treatment of vulvo-vaginal candidosis and leads to fast relieve of the symptoms. It seems to be more effective in acute than in chronic VVC. The main advantages are very convenient and easy way of application using a single dose applicator and reported an excellent compliance. The patients did not reported adverse effects in practice. On the basis of literature and our experience we can recommend GYNAZOL vaginal cream for wide use in everyday gynecological practice.
Rachev
E
E
D000282:Administration, Intravaginal; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014622:Vaginal Creams, Foams, and Jellies
D000935:Antifungal Agents; D007093:Imidazoles; D014622:Vaginal Creams, Foams, and Jellies; C017125:butoconazole